Predicative factors for Pegylated interferon-α plus ribavirin combination therapy in Egyptian patients with chronic Hepatitis Cinfected with genotype 4

Autor: Massoud, SM, Shemis, MA, Drees, EA, Taha, MA, Omar, HA, Saber, MA

Publikováno v: Egyptian Journal of Biochemistry and Molecular Biology; Vol 32, No 2 (2014); 132-153

Background:Hepatitis C virus genotype 4 is a common infection in Egypt and is the leading cause of liver disease. Most reports suggest that predicative factors for the efficacy of interferon α and ribavirincombination therapy for chronic hepatitis p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::df588bc1d8cd501601bd24435daa0505
https://www.ajol.info/index.php/ejbmb/article/view/112868

Phytoconstituent analysis, anti-inflammatory, antimicrobial and anticancer effects of nano encapsulated Convolvulus arvensis L. extracts.

Autor: Osman EEA; Department of Medicinal Chemistry, Theodor Bilharz Research Institute, Kornaish El-Nile St, Giza, 12411, Egypt. ezzat_ea@yahoo.com., Shemis MA; Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Kornaish El-Nile St, Giza, 12411, Egypt., Abdel-Hameed ES; Department of Medicinal Chemistry, Theodor Bilharz Research Institute, Kornaish El-Nile St, Giza, 12411, Egypt., Gouda AE; Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Kornaish El-Nile St, Giza, 12411, Egypt., Hassan H; Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Kornaish El-Nile St, Giza, 12411, Egypt., Atef N; Air Force Specialized Hospital, Cairo, 19448, Egypt., Mamdouh S; Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Kornaish El-Nile St, Giza, 12411, Egypt.

Publikováno v: BMC complementary medicine and therapies [BMC Complement Med Ther] 2024 Mar 14; Vol. 24 (1), pp. 122. Date of Electronic Publication: 2024 Mar 14.

Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system.

Autor: Fahmi A; Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt., Abdur-Rahman M; Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt. mariam@sci.cu.edu.eg., Mahareek O; Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt., Shemis MA; Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt.

Publikováno v: BMC chemistry [BMC Chem] 2022 Nov 12; Vol. 16 (1), pp. 95. Date of Electronic Publication: 2022 Nov 12.

Influence of Blastocystis hominis on the small intestine and lactase enzyme activity.

Autor: Basuony GA; Parasitology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt., M A Basyoni M; Parasitology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt., Negm MSI; Pathology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt., Mostafa EAM; Parasitology department, Theodor Bilharz Research Institute, Cairo, Egypt., El-Wakil ES; Parasitology department, Theodor Bilharz Research Institute, Cairo, Egypt., Shemis MA; Biochemistry and Molecular Biology Department, Theodore Bilharz Research Institute, Giza, Egypt., Gouda AE; Biochemistry and Molecular Biology Department, Theodore Bilharz Research Institute, Giza, Egypt., Saftawy EAE; Parasitology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.; Medical Parasitology Department, College of Medicine, Armed Forces College of Medicine (AFCM), Cairo, Egypt.

Publikováno v: Journal of parasitic diseases : official organ of the Indian Society for Parasitology [J Parasit Dis] 2022 Mar; Vol. 46 (1), pp. 243-253. Date of Electronic Publication: 2021 Aug 24.

Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin.

Autor: Tshweu LL; Biopolymer Modification & Therapeutics Lab, Chemicals Cluster, Council for Scientific and Industrial Research Pretoria 0001 South Africa mbalogun@csir.co.za mohammedbalogun@tuks.co.za.; Department of Chemistry, University of Pretoria Pretoria South Africa., Shemis MA; Biochemistry & Molecular Biology Department, Theodor Bilharz Research Institute Warak El-Hadar, Kornish El-Nile, P.O. Box 30, Imbaba 12411-Giza Egypt., Abdelghany A; Biochemistry & Molecular Biology Department, Theodor Bilharz Research Institute Warak El-Hadar, Kornish El-Nile, P.O. Box 30, Imbaba 12411-Giza Egypt., Gouda A; Biochemistry & Molecular Biology Department, Theodor Bilharz Research Institute Warak El-Hadar, Kornish El-Nile, P.O. Box 30, Imbaba 12411-Giza Egypt., Pilcher LA; Department of Chemistry, University of Pretoria Pretoria South Africa., Sibuyi NRS; DST/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape Cape Town South Africa., Meyer M; DST/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape Cape Town South Africa., Dube A; Infectious Disease Nanomedicine Research Group, School of Pharmacy, University of the Western Cape Cape Town South Africa., Balogun MO; Biopolymer Modification & Therapeutics Lab, Chemicals Cluster, Council for Scientific and Industrial Research Pretoria 0001 South Africa mbalogun@csir.co.za mohammedbalogun@tuks.co.za.

Publikováno v: RSC advances [RSC Adv] 2020 May 26; Vol. 10 (34), pp. 19770-19780. Date of Electronic Publication: 2020 May 26 (Print Publication: 2020).